Integrated bioinformatics analysis and experimental validation reveal Pevonedistat as a promising therapeutic agent modulating the CRL4–DTL–p21/p53 axis in nasopharyngeal carcinoma

Abstract Background Nasopharyngeal carcinoma (NPC) continues to represent a significant therapeutic challenge. Despite the substantial success of radiotherapy, chemotherapy, and immunotherapy, their effectiveness remains limited in recurrent or advanced NPC. Hence, the urgent identification of new m...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Cong-Chao Jia, Zhen-Yi Li, Wei-Hua Jia, Cheng-Tao Jiang
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2026-03-01
Cyfres:	Hereditas
Pynciau:	Nasopharyngeal carcinoma DTL Pevonedistat Machine learning Molecular docking PDX models
Mynediad Ar-lein:	https://doi.org/10.1186/s41065-026-00661-2
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!